How Australia and Aotearoa New Zealand avoided large-scale mpox (formerly monkeypox) outbreaks in 2022-2023
Intern Med J
.
2023 Oct;53(10):1732-1738.
doi: 10.1111/imj.16236.
Authors
Vincent J Cornelisse
1
2
3
4
,
Dash Heath-Paynter
3
5
,
Valerie Delpech
6
,
Phillip Read
3
7
,
Alexis Apostolellis
2
,
Nicholas A Medland
2
3
,
C Raina MacIntyre
3
,
Massimo Giola
8
,
Michael Kidd
9
10
11
Affiliations
1
Sydney Local Health District and Northern Sydney Local Health District, NSW Health, New South Wales, Sydney, Australia.
2
ASHM (the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine), Sydney, New South Wales, Australia.
3
The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
4
Monash University, Melbourne, Victoria, Australia.
5
Health Equity Matters, Sydney, New South Wales, Australia.
6
Mid North Coast Local Health District, Port Macquarie, New South Wales, Australia.
7
South Eastern Sydney Local Health District, Sydney, New South Wales, Australia.
8
Te Whatu Ora - Hauora a Toi and Lakes Districts, Aotearoa, New Zealand.
9
Centre for Future Health Systems, University of New South Wales, Sydney, New South Wales, Australia.
10
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
11
College of Health and Medicine, The Australian National University, Canberra, Australian Capital Territory, Australia.
PMID:
37859543
DOI:
10.1111/imj.16236
No abstract available
Publication types
Editorial
MeSH terms
Australia / epidemiology
Disease Outbreaks / prevention & control
Humans
Mpox (monkeypox)*
New Zealand / epidemiology